Shigeki Miyamoto

University of Wisconsin Carbone Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “IκBα Nuclear Export Enables 4-1BB–Induced cRel Activation and IL-2 Production to Promote CD8 T Cell Immunity”.

IκBα Nuclear Export Enables 4-1BB–Induced cRel Activation and IL-2 Production to Promote CD8 T Cell Immunity

The Journal of Immunology(2020)10.4049/jimmunol.2000039

N/A

0.385DataRank · unranked

12 citations

Cheng Zhang, Melba Marie Tejera, Brandon Neldner, Jay W. Warrick, Shelly M. Wuerzberger‐Davis +4 more

NF-κB Induction of the SUMO Protease SENP2: A Negative Feedback Loop to Attenuate Cell Survival Response to Genotoxic Stress

UNC Libraries(2020)10.17615/wnqz-v791

N/A

0DataRank · unranked

0 citations

Edward T.H. Yeh, Shigeki Miyamoto, Angela M. Mabb, Grace Gill, Moon Hee Lee

Timelapse viability assay to detect division and death of primary multiple myeloma cells in response to drug treatments with single cell resolution

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.12.467843

N/A

0DataRank · unranked

0 citations

Natalie S. Callander, Kenny Chng, Shigeki Miyamoto, Jay W. Warrick, Christina Mark

A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0941

N/A

0DataRank · unranked

13 citations

Jay W. Warrick, Natalie S. Callander, Peiman Hematti, Shigeki Miyamoto, Christina Mark

The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells

Oncogenesis(2022)10.1038/s41389-022-00440-4

N/A

0DataRank · unranked

11 citations

Kyung E. Sung, David J. Beebe, Wei Huang, Dan Shapiro, Shigeki Miyamoto +2 more

HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs

PLoS ONE(2022)10.1371/journal.pone.0274704

N/A

0DataRank · unranked

4 citations

Hae Yeun Chang, Dominique N. Lisiero, Irene M. Ong, Trinayan Kashyap, Natalie S. Callander +2 more

Ectopic CH60 mediates HAPLN1-induced cell survival signaling in multiple myeloma

Life Science Alliance(2022)10.26508/lsa.202201636

N/A

0DataRank · unranked

3 citations

Yu-Chia Chen, Shelly M. Wuerzberger‐Davis, M Ma, Bayley J. Waters, Lingjun Li +3 more

Timelapse viability assay to detect division and death of primary multiple myeloma cells in response to drug treatments with single cell resolution

Integrative Biology(2022)10.1093/intbio/zyac006

N/A

0DataRank · unranked

1 citations

Natalie S. Callander, Kenny Chng, Shigeki Miyamoto, Jay W. Warrick, Christina Mark

Splicing and Dicing: A Deeper Dive Into CaMKIIδ and Cardiac Inflammation

Circulation Research(2022)10.1161/circresaha.122.320881

N/A

0DataRank · unranked

3 citations

Shigeki Miyamoto, Joan Heller Brown

HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM

Blood Advances(2023)10.1182/bloodadvances.2023010139

N/A

0DataRank · unranked

5 citations

Mailee Huynh, Avtar Roopra, Natalie S. Callander, Shigeki Miyamoto, Hae Yeun Chang

Data from NFKB1 Is a Direct Target of the TAL1 Oncoprotein in Human T Leukemia Cells

(2023)10.1158/0008-5472.c.6494396

N/A

0DataRank · unranked

0 citations

Kyle Draheim, Michelle A. Kelliher, Shigeki Miyamoto, Pei-Yun Chang

Data from NFKB1 Is a Direct Target of the TAL1 Oncoprotein in Human T Leukemia Cells

(2023)10.1158/0008-5472.c.6494396.v1

N/A

0DataRank · unranked

0 citations

Kyle Draheim, Michelle A. Kelliher, Shigeki Miyamoto, Pei-Yun Chang

Data from Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells

(2023)10.1158/1541-7786.c.6542187.v1

N/A

0DataRank · unranked

0 citations

Natalie S. Callander, Shelby L. O’Connor, Jihoon Kim, Jae Werndli, Martha Raschko +5 more